A Olotu, G Fegan, J Wambua, G Nyangweso… - New England journal …, 2013 - ora.ox.ac.uk
BACKGROUND: The candidate malaria vaccine RTS, S/AS01E has entered phase 3 trials,
but data on long-term outcomes are limited. METHODS: For 4 years, we followed children …